Vanguard Group's Disclosure on Mural Oncology Stake

On July 3, 2025, The Vanguard Group, Inc. disclosed its interest in Mural Oncology plc as per the Irish Takeover Panel's requirements. Vanguard reported ownership of 772,835 ordinary shares, representing 4.48% of Mural Oncology's securities. This disclosure, dated July 2, 2025, reveals no additional agreements or options related to the securities, indicating a straightforward equity position without complex derivatives or additional financial instruments involved. Furthermore, a recent transaction included the sale of 16 shares at a price of 2.51 USD per share.

No other parties apart from Mural Oncology are part of this disclosure by Vanguard. No indemnity or option arrangements were reported, highlighting the absence of inducements or strategic financial maneuvers regarding Mural Oncology's shares. The form confirms no additional disclosures or attached supplements, underscoring Vanguard's direct stake in the firm.